← Eichor
Study identifier: NCT05407168 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Condition: Lung Carcinoma  ·  Sponsor: OHSU Knight Cancer Institute

PhaseNA
Planned participants300
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (4)

Hillsboro Medical CenterHillsboro, Oregon, United StatesRecruiting
Adventist Health PortlandPortland, Oregon, United StatesRecruiting
OHSU Knight Cancer InstitutePortland, Oregon, United StatesRecruiting
Portland VA Medical CenterPortland, Oregon, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05407168